By Gasporox AB
Showcasing non-destructive GPX1500 CCIT testing of parenterals at PDA 2025 Malaga
Lund, Sweden: – Non-destructive testing technology specialist Gasporox AB is returning for a fourth successive year to a Parenteral Drug Association event, this time the PDA 2025 Annual Conference at Malaga, southern Spain.
As an exhibitor at PDA 2025, Gasporox will use the meeting as a platform to showcase its GPX1500™ Vial O2 and CO2 as well as GPX1500 Film Pharma O2 benchtop instant oxygen headspace gas analysis instruments for CCIT Container Closure Integrity Testing of glass and flexible containers.
Instant desktop measurement
Gasporox will exhibit from Table 39 at the Higueron Hotel venue, with live demonstrations of the compact desktop GPX1500 instruments’ ability to instantly measure the oxygen and carbon dioxide levels in the headspace of sealed glass vials and film packages.
The Gasporox stand will also show a display version of the VialArch™ in-line sensor module, to highlight its compact and easily mounted form. The stand team will be able to explain how this application of its TDLAS tuneable laser absorption spectroscopy technology can be extended to production line testing of small volume parenterals. Gasporox is also developing a further BottleArch™ module for in-line testing of larger volume containers.
Area Sales and Product Manager Niklas Bohlin, who will be among the Gasporox team in Malaga, commented: “The PDA meetings are always must-attend events for us, as excellent platforms to connect with our core audience for laser sensor package solution integrity testing of parenteral drug products.”
“For this event, we are particularly keen to demonstrate the abilities of our ‘Connect and Go’; GPX1500 Film Pharma O2 version as well as GPX1500 Vial O2 and CO2 to meet regulatory closure integrity requirements like Annex 1 without compromising the product” he explained.
About Gasporox
Gasporox, based in Lund in southern Sweden, develops and manufactures laser-based sensors for integration into in-line inspection and production lines for Headspace Analysis and Leak Detection. Gasporox sensors are also available in various instruments ideal for quality control and at-line inspection of packaging and support many different package formats as highly effective tools for more efficient sample testing and greener production.
The VialArch™ is a unique laser-based solution for vials to be installed on the production line for 100% quality inspection for residual oxygen and container closure integrity testing. The laser beam is passing the headspace of the moving vials to perform laser-based headspace analysis (HSA), non-destructive and with precise measurements of the residual oxygen in the headspace.
The GPX1500 Film Pharma is a compact and easy to use instrument to measure accurate the headspace of pharmaceutical bags and pouches. It’s designed to operate parameter free to have a reliable and accurate use in the pharmaceutical production and lab. The GPX1500 Vial is the Film Pharma’s sibling for rigid containers, like vials and ampoules.
The available Headspace Analysis sensors work with many types of containers like vials, ampoules, bottles, bags and trays and are available for measuring O2, CO2, H2O, or the pressure inside the inspected container and are suitable for Leak Detection on packages like trays, bags. These sensors can be integrated into production machines or form the basis for stand-alone instruments.
Gasporox technology has been proven for performance and robustness over more than a decade in the pharmaceutical industry in the testing of parenteral drugs. It is integrated and used in machines, systems and instruments for total lab and production testing of vials and ampoules in many parenteral packaging lines.
Gasporox testing technologies are non-destructive and deterministic and recommended by <USP1207>.
Learn more at: www.gasporox.com
About PDA Parenteral Packaging Conference 2025
The Parenteral Drug Association (PDA) series of meetings have become pharma industry reference events for high quality knowledge sharing on all aspects of the drug-package interface.
The 2025 PDA Annual Conference, themed ‘15 Years of Advancing Parenteral Packaging Technologies – What will the Next 15 Years Bring?’ will be a two-day event opening March 25 at the Hotel Higueron in Malaga, Spain.
Topics on the agenda will include PFAS regulations, Container Closure Integrity Testing (CCIT), sustainability initiatives, and innovative packaging solutions. Alongside the plenary and parallel sessions, the conference will feature workshops on sterilization and cold chain solutions.
The event is organized by the PDA with further information at: https://www.pda.org/global-event-calendar/event-detail/pda-parenteral-packaging-conference-2025
Resources
Click on GPX1500 Vial for product information.
Click on GPX1500 Film Pharma for product information.
Click on GPX Vial for video presentation.
Click on VialArch™ to learn more about in-line testing.